Company’s Responsibilities. (a) COMPANY will transfer to DPT the Product formulation, tests and other technology and information (collectively, the “Company Technology”). All Company Technology shall be and shall remain the sole property of COMPANY and shall be deemed Company Confidential Information, subject to Sections 5.1 — 5.4. COMPANY hereby grants to DPT a non-exclusive, nontransferable, royalty-free license to use the Company Technology solely for purposes of performing the Services.
Appears in 5 contracts
Samples: Development and Clinical Supply Agreement, Development and Clinical Supply Agreement (Peplin Inc), Development and Clinical Supply Agreement (Peplin Inc)
